The Blood Viscometers Market is expected to register a CAGR of 5.1% from 2025 to 2031, with a market size expanding from US$ XX million in 2024 to US$ XX Million by 2031.
The report is segmented by Product Type (Rotational Viscometers, Capillary Viscometers and Others). The report further presents analysis based on the End User (Hospitals, Laboraories, Clinics, and Others). The global analysis is further broken-down at regional level and major countries. The Report Offers the Value in USD for the above analysis and segments.
Purpose of the ReportThe report Blood Viscometers Market by The Insight Partners aims to describe the present landscape and future growth, top driving factors, challenges, and opportunities. This will provide insights to various business stakeholders, such as:
- Technology Providers/Manufacturers: To understand the evolving market dynamics and know the potential growth opportunities, enabling them to make informed strategic decisions.
- Investors: To conduct a comprehensive trend analysis regarding the market growth rate, market financial projections, and opportunities that exist across the value chain.
- Regulatory bodies: To regulate policies and police activities in the market with the aim of minimizing abuse, preserving investor trust and confidence, and upholding the integrity and stability of the market.
Blood Viscometers Market Segmentation
Product Type- Rotational Viscometers
- Capillary Viscometers
- Others
- Hospitals
- Laboraories
- Clinics
- Others
Strategic Insights
Blood Viscometers Market Growth Drivers- Increasing prevalence of CVDs: The increasing prevalence of cardiovascular diseases (CVDs) and other chronic conditions has led to a higher demand for blood viscometers globally. For instance, according to the World Health Organization, CVDs are the leading cause of death globally, taking an estimated 17.9 million lives every year According to Centers of Disease Control and Prevention, about 1 in 20 adults aged 20 and older have coronary artery disease.
- Increasing elderly population: The aging population drastically influences blood viscosity and diseases associated with it. The intrinsic changes in blood associated with the aging process include increased red blood cell mass and alterations of plasma proteins that increase blood viscosity. The other disorder of blood characterized by the increased production of red blood cells is more common among the elderly and contributes to higher blood viscosity.
- Awareness about blood disorders: Raising awareness about blood disorders and the role of a viscometer may play an essential role in the diagnosis and management of these diseases. Blood Viscometers instruments measure the viscosity of blood, thus aiding in the assessment of how disorders might impact blood flow. High viscosity often causes complications such as clotting or stroke. Enhanced awareness regarding the implications of blood viscosity and the utility of a viscometer will facilitate patients afflicted by blood disorders to find better clinical outcomes.
- Demand POCT: Point-of-care blood viscometers produce prompt results; therefore, decisions in the clinical arena can now be made immediately. They help reduce processing time in a laboratory and enhance patient and even emergency management. Furthermore, they are mobile and taken for testing into different environments, which increases accessibility and convenience.
- Miniaturization and portability: Miniaturization and portability have been attained in blood viscometers. Such makes the application use them easily in hospitals, clinics, and even home, therefore improving the levels of accessibility at any place for fast assessment without big equipment. It has allowed more frequent monitoring, which might be essential for controlling conditions associated with blood viscosity.
- Automation: Automated blood viscometers make the measurement process easier through several advantages. Most of the automated viscometers can communicate with laboratory information systems, hence making the management of the data more effective and integration with electronic health records easier. Automation minimizes the risk of human error and results are better reproducible and reliable. Some models in viscometers have different testing parameters such as viscosity and hematocrit which can be evaluated as a single sample. Overall, automated blood viscometers enhance the flow in clinical setups and improve patients' outcome.
- Integration with Digital Health: Integrating blood viscometers into digital health technology can really make a big difference in the treatment and care of patients suffering from blood disorders. Continuous or periodic monitoring via digital health platforms would ultimately result in real-time data access and analysis. Telehealth service can also serve as support for remote monitoring where the patients would manage their condition at home, but the providers follow their blood viscosity level. Some other applications that are considered to be potential emerging technologies include wearable viscometers that can monitor blood viscosity in real time, providing patients and health care providers with ongoing feedback.
- Collaboration by companies: Collaboration in research to develop blood viscometers can significantly improve the development and application of such devices. Researchers can team with various universities in bringing together hematologists, engineers as well as data scientists to innovate viscometer technologies. Biotech companies or manufacturers of medical devices can be involved for more resources and expertise in making advanced viscometers.
- Regulatory Approval: Blood viscometers seek regulatory approval, which remains an opportunity to innovate and grow in terms of business. Obtaining approval from such regulatory agencies as the FDA for US clients and EMA for European clients opens the international markets, thereby increasing sales and distribution. Lure of collaborative arrangements with hospitals and research institutions regarding more clinical trials and studies that can be undertaken to validate product legitimacy.
Market Report Scope
Key Selling Points
- Comprehensive Coverage: The report comprehensively covers the analysis of products, services, types, and end users of the Blood Viscometers Market, providing a holistic landscape.
- Expert Analysis: The report is compiled based on the in-depth understanding of industry experts and analysts.
- Up-to-date Information: The report assures business relevance due to its coverage of recent information and data trends.
- Customization Options: This report can be customized to cater to specific client requirements and suit the business strategies aptly.
The research report on the Blood Viscometers Market can, therefore, help spearhead the trail of decoding and understanding the industry scenario and growth prospects. Although there can be a few valid concerns, the overall benefits of this report tend to outweigh the disadvantages.
REGIONAL FRAMEWORK
Have a question?
Mrinal
Mrinal will walk you through a 15-minute call to present the report’s content and answer all queries if you have any.
Speak to Analyst
- Sample PDF showcases the content structure and the nature of the information with qualitative and quantitative analysis.
- Request discounts available for Start-Ups & Universities
- Sample PDF showcases the content structure and the nature of the information with qualitative and quantitative analysis.
- Request discounts available for Start-Ups & Universities
Report Coverage
Revenue forecast, Company Analysis, Industry landscape, Growth factors, and Trends
Segment Covered
This text is related
to segments covered.
Regional Scope
North America, Europe, Asia Pacific, Middle East & Africa, South & Central America
Country Scope
This text is related
to country scope.
Frequently Asked Questions
Players operating in the market are Thermo Fisher Scientific, Microsil India, RheoSense, Benson, Ametek Brookfeild, Acutek, Lasany, and PCE Instruments
Rotational viscometers segment, by product, dominated the market in 2023.
The Blood Viscometers Market is estimated to witness a CAGR of 5.1% from 2023 to 2031
North America region dominated the Ophthalmic Lasers market in 2023.
Integration with Digital Health act as a opportunity for growth of the market in forecast period.
The major factors driving the Blood Viscometers market are:
1. Increasing prevalence of CVDs
2.Awareness about blood disorders
1. INTRODUCTION
1.1. SCOPE OF THE STUDY
1.2. THE INSIGHT PARTNERS RESEARCH REPORT GUIDANCE
1.3. MARKET SEGMENTATION
1.3.1 Blood Viscometers Market - By Product Type
1.3.2 Blood Viscometers Market - By End Use
1.3.3 Blood Viscometers Market - By Region
1.3.3.1 By Country
2. KEY TAKEAWAYS
3. RESEARCH METHODOLOGY
4. BLOOD VISCOMETERS MARKET LANDSCAPE
4.1. OVERVIEW
4.2. PEST ANALYSIS
4.2.1 North America - Pest Analysis
4.2.2 Europe - Pest Analysis
4.2.3 Asia-Pacific - Pest Analysis
4.2.4 Middle East and Africa - Pest Analysis
4.2.5 South and Central America - Pest Analysis
4.3. EXPERT OPINIONS
5. BLOOD VISCOMETERS MARKET - KEY MARKET DYNAMICS
5.1. KEY MARKET DRIVERS
5.2. KEY MARKET RESTRAINTS
5.3. KEY MARKET OPPORTUNITIES
5.4. FUTURE TRENDS
5.5. IMPACT ANALYSIS OF DRIVERS AND RESTRAINTS
6. BLOOD VISCOMETERS MARKET - GLOBAL MARKET ANALYSIS
6.1. BLOOD VISCOMETERS - GLOBAL MARKET OVERVIEW
6.2. BLOOD VISCOMETERS - GLOBAL MARKET AND FORECAST TO 2028
6.3. MARKET POSITIONING
7. BLOOD VISCOMETERS MARKET - REVENUE AND FORECASTS TO 2028 - PRODUCT TYPE
7.1. OVERVIEW
7.2. PRODUCT TYPE MARKET FORECASTS AND ANALYSIS
7.3. ROTATIONAL VISCOMETERS
7.3.1. Overview
7.3.2. Rotational Viscometers Market Forecast and Analysis
7.4. CAPILLARY VISCOMETERS
7.4.1. Overview
7.4.2. Capillary Viscometers Market Forecast and Analysis
7.5. OTHERS
7.5.1. Overview
7.5.2. Others Market Forecast and Analysis
8. BLOOD VISCOMETERS MARKET - REVENUE AND FORECASTS TO 2028 - END USE
8.1. OVERVIEW
8.2. END USE MARKET FORECASTS AND ANALYSIS
8.3. HOSPITALS
8.3.1. Overview
8.3.2. Hospitals Market Forecast and Analysis
8.4. LABORAORIES
8.4.1. Overview
8.4.2. Laboraories Market Forecast and Analysis
8.5. CLINICS
8.5.1. Overview
8.5.2. Clinics Market Forecast and Analysis
8.6. OTHERS
8.6.1. Overview
8.6.2. Others Market Forecast and Analysis
9. BLOOD VISCOMETERS MARKET REVENUE AND FORECASTS TO 2028 - GEOGRAPHICAL ANALYSIS
9.1. NORTH AMERICA
9.1.1 North America Blood Viscometers Market Overview
9.1.2 North America Blood Viscometers Market Forecasts and Analysis
9.1.3 North America Blood Viscometers Market Forecasts and Analysis - By Product Type
9.1.4 North America Blood Viscometers Market Forecasts and Analysis - By End Use
9.1.5 North America Blood Viscometers Market Forecasts and Analysis - By Countries
9.1.5.1 United States Blood Viscometers Market
9.1.5.1.1 United States Blood Viscometers Market by Product Type
9.1.5.1.2 United States Blood Viscometers Market by End Use
9.1.5.2 Canada Blood Viscometers Market
9.1.5.2.1 Canada Blood Viscometers Market by Product Type
9.1.5.2.2 Canada Blood Viscometers Market by End Use
9.1.5.3 Mexico Blood Viscometers Market
9.1.5.3.1 Mexico Blood Viscometers Market by Product Type
9.1.5.3.2 Mexico Blood Viscometers Market by End Use
9.2. EUROPE
9.2.1 Europe Blood Viscometers Market Overview
9.2.2 Europe Blood Viscometers Market Forecasts and Analysis
9.2.3 Europe Blood Viscometers Market Forecasts and Analysis - By Product Type
9.2.4 Europe Blood Viscometers Market Forecasts and Analysis - By End Use
9.2.5 Europe Blood Viscometers Market Forecasts and Analysis - By Countries
9.2.5.1 Germany Blood Viscometers Market
9.2.5.1.1 Germany Blood Viscometers Market by Product Type
9.2.5.1.2 Germany Blood Viscometers Market by End Use
9.2.5.2 France Blood Viscometers Market
9.2.5.2.1 France Blood Viscometers Market by Product Type
9.2.5.2.2 France Blood Viscometers Market by End Use
9.2.5.3 Italy Blood Viscometers Market
9.2.5.3.1 Italy Blood Viscometers Market by Product Type
9.2.5.3.2 Italy Blood Viscometers Market by End Use
9.2.5.4 Spain Blood Viscometers Market
9.2.5.4.1 Spain Blood Viscometers Market by Product Type
9.2.5.4.2 Spain Blood Viscometers Market by End Use
9.2.5.5 United Kingdom Blood Viscometers Market
9.2.5.5.1 United Kingdom Blood Viscometers Market by Product Type
9.2.5.5.2 United Kingdom Blood Viscometers Market by End Use
9.2.5.6 Rest of Europe Blood Viscometers Market
9.2.5.6.1 Rest of Europe Blood Viscometers Market by Product Type
9.2.5.6.2 Rest of Europe Blood Viscometers Market by End Use
9.3. ASIA-PACIFIC
9.3.1 Asia-Pacific Blood Viscometers Market Overview
9.3.2 Asia-Pacific Blood Viscometers Market Forecasts and Analysis
9.3.3 Asia-Pacific Blood Viscometers Market Forecasts and Analysis - By Product Type
9.3.4 Asia-Pacific Blood Viscometers Market Forecasts and Analysis - By End Use
9.3.5 Asia-Pacific Blood Viscometers Market Forecasts and Analysis - By Countries
9.3.5.1 Australia Blood Viscometers Market
9.3.5.1.1 Australia Blood Viscometers Market by Product Type
9.3.5.1.2 Australia Blood Viscometers Market by End Use
9.3.5.2 China Blood Viscometers Market
9.3.5.2.1 China Blood Viscometers Market by Product Type
9.3.5.2.2 China Blood Viscometers Market by End Use
9.3.5.3 India Blood Viscometers Market
9.3.5.3.1 India Blood Viscometers Market by Product Type
9.3.5.3.2 India Blood Viscometers Market by End Use
9.3.5.4 Japan Blood Viscometers Market
9.3.5.4.1 Japan Blood Viscometers Market by Product Type
9.3.5.4.2 Japan Blood Viscometers Market by End Use
9.3.5.5 South Korea Blood Viscometers Market
9.3.5.5.1 South Korea Blood Viscometers Market by Product Type
9.3.5.5.2 South Korea Blood Viscometers Market by End Use
9.3.5.6 Rest of Asia-Pacific Blood Viscometers Market
9.3.5.6.1 Rest of Asia-Pacific Blood Viscometers Market by Product Type
9.3.5.6.2 Rest of Asia-Pacific Blood Viscometers Market by End Use
9.4. MIDDLE EAST AND AFRICA
9.4.1 Middle East and Africa Blood Viscometers Market Overview
9.4.2 Middle East and Africa Blood Viscometers Market Forecasts and Analysis
9.4.3 Middle East and Africa Blood Viscometers Market Forecasts and Analysis - By Product Type
9.4.4 Middle East and Africa Blood Viscometers Market Forecasts and Analysis - By End Use
9.4.5 Middle East and Africa Blood Viscometers Market Forecasts and Analysis - By Countries
9.4.5.1 South Africa Blood Viscometers Market
9.4.5.1.1 South Africa Blood Viscometers Market by Product Type
9.4.5.1.2 South Africa Blood Viscometers Market by End Use
9.4.5.2 Saudi Arabia Blood Viscometers Market
9.4.5.2.1 Saudi Arabia Blood Viscometers Market by Product Type
9.4.5.2.2 Saudi Arabia Blood Viscometers Market by End Use
9.4.5.3 U.A.E Blood Viscometers Market
9.4.5.3.1 U.A.E Blood Viscometers Market by Product Type
9.4.5.3.2 U.A.E Blood Viscometers Market by End Use
9.4.5.4 Rest of Middle East and Africa Blood Viscometers Market
9.4.5.4.1 Rest of Middle East and Africa Blood Viscometers Market by Product Type
9.4.5.4.2 Rest of Middle East and Africa Blood Viscometers Market by End Use
9.5. SOUTH AND CENTRAL AMERICA
9.5.1 South and Central America Blood Viscometers Market Overview
9.5.2 South and Central America Blood Viscometers Market Forecasts and Analysis
9.5.3 South and Central America Blood Viscometers Market Forecasts and Analysis - By Product Type
9.5.4 South and Central America Blood Viscometers Market Forecasts and Analysis - By End Use
9.5.5 South and Central America Blood Viscometers Market Forecasts and Analysis - By Countries
9.5.5.1 Brazil Blood Viscometers Market
9.5.5.1.1 Brazil Blood Viscometers Market by Product Type
9.5.5.1.2 Brazil Blood Viscometers Market by End Use
9.5.5.2 Argentina Blood Viscometers Market
9.5.5.2.1 Argentina Blood Viscometers Market by Product Type
9.5.5.2.2 Argentina Blood Viscometers Market by End Use
9.5.5.3 Rest of South and Central America Blood Viscometers Market
9.5.5.3.1 Rest of South and Central America Blood Viscometers Market by Product Type
9.5.5.3.2 Rest of South and Central America Blood Viscometers Market by End Use
10. IMPACT OF COVID-19 PANDEMIC ON GLOBAL BLOOD VISCOMETERS MARKET
10.1 North America
10.2 Europe
10.3 Asia-Pacific
10.4 Middle East and Africa
10.5 South and Central America
11. INDUSTRY LANDSCAPE
11.1. MERGERS AND ACQUISITIONS
11.2. AGREEMENTS, COLLABORATIONS AND JOIN VENTURES
11.3. NEW PRODUCT LAUNCHES
11.4. EXPANSIONS AND OTHER STRATEGIC DEVELOPMENTS
12. BLOOD VISCOMETERS MARKET, KEY COMPANY PROFILES
12.1. THERMO FISHER SCIENTIFIC INC.
12.1.1. Key Facts
12.1.2. Business Description
12.1.3. Products and Services
12.1.4. Financial Overview
12.1.5. SWOT Analysis
12.1.6. Key Developments
12.2. ANTON PAAR GMBH
12.2.1. Key Facts
12.2.2. Business Description
12.2.3. Products and Services
12.2.4. Financial Overview
12.2.5. SWOT Analysis
12.2.6. Key Developments
12.3. RHEOSENSE, INC.
12.3.1. Key Facts
12.3.2. Business Description
12.3.3. Products and Services
12.3.4. Financial Overview
12.3.5. SWOT Analysis
12.3.6. Key Developments
12.4. BROOKFIELD ASSET MANAGEMENT INC.
12.4.1. Key Facts
12.4.2. Business Description
12.4.3. Products and Services
12.4.4. Financial Overview
12.4.5. SWOT Analysis
12.4.6. Key Developments
12.5. BIOFLUID TECHNOLOGIES
12.5.1. Key Facts
12.5.2. Business Description
12.5.3. Products and Services
12.5.4. Financial Overview
12.5.5. SWOT Analysis
12.5.6. Key Developments
12.6. HEALTH ONVECTOR
12.6.1. Key Facts
12.6.2. Business Description
12.6.3. Products and Services
12.6.4. Financial Overview
12.6.5. SWOT Analysis
12.6.6. Key Developments
12.7. LAMY RHEOLOGY
12.7.1. Key Facts
12.7.2. Business Description
12.7.3. Products and Services
12.7.4. Financial Overview
12.7.5. SWOT Analysis
12.7.6. Key Developments
12.8. BENSON VISCOMETERS
12.8.1. Key Facts
12.8.2. Business Description
12.8.3. Products and Services
12.8.4. Financial Overview
12.8.5. SWOT Analysis
12.8.6. Key Developments
12.9. HRD ANTWERP
12.9.1. Key Facts
12.9.2. Business Description
12.9.3. Products and Services
12.9.4. Financial Overview
12.9.5. SWOT Analysis
12.9.6. Key Developments
12.10. LAUDA-BRINKMANN, LP.
12.10.1. Key Facts
12.10.2. Business Description
12.10.3. Products and Services
12.10.4. Financial Overview
12.10.5. SWOT Analysis
12.10.6. Key Developments
13. APPENDIX
13.1. ABOUT THE INSIGHT PARTNERS
13.2. GLOSSARY OF TERMS
1. Thermo Fisher Scientific Inc.
2. Anton Paar GmbH
3. RheoSense, Inc
4. Brookfield Asset Management Inc.
5. BioFluid Technologies
6. Health Onvector
7. Lamy Rheology
8. Benson Viscometers
9. HRD Antwerp
10. LAUDA-Brinkmann, LP.
The Insight Partners performs research in 4 major stages: Data Collection & Secondary Research, Primary Research, Data Analysis and Data Triangulation & Final Review.
- Data Collection and Secondary Research:
As a market research and consulting firm operating from a decade, we have published many reports and advised several clients across the globe. First step for any study will start with an assessment of currently available data and insights from existing reports. Further, historical and current market information is collected from Investor Presentations, Annual Reports, SEC Filings, etc., and other information related to company’s performance and market positioning are gathered from Paid Databases (Factiva, Hoovers, and Reuters) and various other publications available in public domain.
Several associations trade associates, technical forums, institutes, societies and organizations are accessed to gain technical as well as market related insights through their publications such as research papers, blogs and press releases related to the studies are referred to get cues about the market. Further, white papers, journals, magazines, and other news articles published in the last 3 years are scrutinized and analyzed to understand the current market trends.
- Primary Research:
The primarily interview analysis comprise of data obtained from industry participants interview and answers to survey questions gathered by in-house primary team.
For primary research, interviews are conducted with industry experts/CEOs/Marketing Managers/Sales Managers/VPs/Subject Matter Experts from both demand and supply side to get a 360-degree view of the market. The primary team conducts several interviews based on the complexity of the markets to understand the various market trends and dynamics which makes research more credible and precise.
A typical research interview fulfils the following functions:
- Provides first-hand information on the market size, market trends, growth trends, competitive landscape, and outlook
- Validates and strengthens in-house secondary research findings
- Develops the analysis team’s expertise and market understanding
Primary research involves email interactions and telephone interviews for each market, category, segment, and sub-segment across geographies. The participants who typically take part in such a process include, but are not limited to:
- Industry participants: VPs, business development managers, market intelligence managers and national sales managers
- Outside experts: Valuation experts, research analysts and key opinion leaders specializing in the electronics and semiconductor industry.
Below is the breakup of our primary respondents by company, designation, and region:
Once we receive the confirmation from primary research sources or primary respondents, we finalize the base year market estimation and forecast the data as per the macroeconomic and microeconomic factors assessed during data collection.
- Data Analysis:
Once data is validated through both secondary as well as primary respondents, we finalize the market estimations by hypothesis formulation and factor analysis at regional and country level.
- 3.1 Macro-Economic Factor Analysis:
We analyse macroeconomic indicators such the gross domestic product (GDP), increase in the demand for goods and services across industries, technological advancement, regional economic growth, governmental policies, the influence of COVID-19, PEST analysis, and other aspects. This analysis aids in setting benchmarks for various nations/regions and approximating market splits. Additionally, the general trend of the aforementioned components aid in determining the market's development possibilities.
- 3.2 Country Level Data:
Various factors that are especially aligned to the country are taken into account to determine the market size for a certain area and country, including the presence of vendors, such as headquarters and offices, the country's GDP, demand patterns, and industry growth. To comprehend the market dynamics for the nation, a number of growth variables, inhibitors, application areas, and current market trends are researched. The aforementioned elements aid in determining the country's overall market's growth potential.
- 3.3 Company Profile:
The “Table of Contents” is formulated by listing and analyzing more than 25 - 30 companies operating in the market ecosystem across geographies. However, we profile only 10 companies as a standard practice in our syndicate reports. These 10 companies comprise leading, emerging, and regional players. Nonetheless, our analysis is not restricted to the 10 listed companies, we also analyze other companies present in the market to develop a holistic view and understand the prevailing trends. The “Company Profiles” section in the report covers key facts, business description, products & services, financial information, SWOT analysis, and key developments. The financial information presented is extracted from the annual reports and official documents of the publicly listed companies. Upon collecting the information for the sections of respective companies, we verify them via various primary sources and then compile the data in respective company profiles. The company level information helps us in deriving the base number as well as in forecasting the market size.
- 3.4 Developing Base Number:
Aggregation of sales statistics (2020-2022) and macro-economic factor, and other secondary and primary research insights are utilized to arrive at base number and related market shares for 2022. The data gaps are identified in this step and relevant market data is analyzed, collected from paid primary interviews or databases. On finalizing the base year market size, forecasts are developed on the basis of macro-economic, industry and market growth factors and company level analysis.
- Data Triangulation and Final Review:
The market findings and base year market size calculations are validated from supply as well as demand side. Demand side validations are based on macro-economic factor analysis and benchmarks for respective regions and countries. In case of supply side validations, revenues of major companies are estimated (in case not available) based on industry benchmark, approximate number of employees, product portfolio, and primary interviews revenues are gathered. Further revenue from target product/service segment is assessed to avoid overshooting of market statistics. In case of heavy deviations between supply and demand side values, all thes steps are repeated to achieve synchronization.
We follow an iterative model, wherein we share our research findings with Subject Matter Experts (SME’s) and Key Opinion Leaders (KOLs) until consensus view of the market is not formulated – this model negates any drastic deviation in the opinions of experts. Only validated and universally acceptable research findings are quoted in our reports.
We have important check points that we use to validate our research findings – which we call – data triangulation, where we validate the information, we generate from secondary sources with primary interviews and then we re-validate with our internal data bases and Subject matter experts. This comprehensive model enables us to deliver high quality, reliable data in shortest possible time.
Get Free Sample For